Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M82.9Revenue $M3,799Net Margin (%)--Altman Z-Score1.9
Enterprise Value $M-7.5EPS $-1.9Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book0.710-y EBITDA Growth Rate %--Quick Ratio8.1Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio8.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-47.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-123.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M23.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with LIFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LIFEMario Gabelli 2014-03-31 Sold Out -0.47%$75.75 - $76.07
($75.91)
$ 3.50-95%Sold Out0
LIFEJohn Paulson 2014-03-31 Sold Out -0.03%$75.75 - $76.07
($75.91)
$ 3.50-95%Sold Out0
LIFEJoel Greenblatt 2014-03-31 Sold Out -0.03%$75.75 - $76.07
($75.91)
$ 3.50-95%Sold Out0
LIFEJohn Paulson 2013-12-31 Reduce-0.04%$74.72 - $75.78
($75.43)
$ 3.50-95%Reduce -50.48%89,657
LIFEFirst Eagle Investment 2013-12-31 Reduce-0.03%$74.72 - $75.78
($75.43)
$ 3.50-95%Reduce -63.70%72,600
LIFEJoel Greenblatt 2013-12-31 Add0.02%$74.72 - $75.78
($75.43)
$ 3.50-95%Add 320.36%14,885
LIFEJohn Paulson 2013-09-30 Reduce-0.58%$74.06 - $74.96
($74.61)
$ 3.50-95%Reduce -85.90%181,053
LIFEFirst Eagle Investment 2013-09-30 Reduce-0.06%$74.06 - $74.96
($74.61)
$ 3.50-95%Reduce -56.11%200,000
LIFEJoel Greenblatt 2013-09-30 Reduce-0.02%$74.06 - $74.96
($74.61)
$ 3.50-95%Reduce -67.32%3,541
LIFEJohn Paulson 2013-06-30 Reduce-4.93%$64.57 - $74.41
($72.6)
$ 3.50-95%Reduce -91.31%1,284,433
LIFEJohn Rogers 2013-06-30 Sold Out -1.9%$64.57 - $74.41
($72.6)
$ 3.50-95%Sold Out0
LIFERobert Olstein 2013-06-30 Sold Out -1.1%$64.57 - $74.41
($72.6)
$ 3.50-95%Sold Out0
LIFEMeridian Funds 2013-06-30 Sold Out -0.83%$64.57 - $74.41
($72.6)
$ 3.50-95%Sold Out0
LIFERonald Muhlenkamp 2013-06-30 Sold Out -0.67%$64.57 - $74.41
($72.6)
$ 3.50-95%Sold Out0
LIFEMario Gabelli 2013-06-30 Add0.59%$64.57 - $74.41
($72.6)
$ 3.50-95%Add 3187.35%1,311,520
LIFEFirst Eagle Investment 2013-06-30 Buy 0.1%$64.57 - $74.41
($72.6)
$ 3.50-95%New holding455,735
LIFEJoel Greenblatt 2013-06-30 Reduce-0.02%$64.57 - $74.41
($72.6)
$ 3.50-95%Reduce -33.08%10,836
LIFERonald Muhlenkamp 2013-03-31 Reduce-1.77%$49.03 - $65.27
($60.09)
$ 3.50-94%Reduce -76.85%50,000
LIFERobert Olstein 2013-03-31 Reduce-0.62%$49.03 - $65.27
($60.09)
$ 3.50-94%Reduce -38.51%99,000
LIFEJohn Paulson 2013-03-31 Add0.28%$49.03 - $65.27
($60.09)
$ 3.50-94%Add 5.53%14,773,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LIFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LIFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCHIMMEL PAULDirector 2016-04-14Buy66,219$4.18-16.27view
SCHIMMEL PAULDirector 2016-04-13Buy9,835$3.85-9.09view
SCHIMMEL PAULDirector 2016-04-12Buy9,127$3.71-5.66view
SCHIMMEL PAULDirector 2016-04-11Buy32,659$3.57-1.96view
SCHIMMEL PAULDirector 2016-04-11Buy32,659$3.57-1.96view
SCHIMMEL PAULDirector 2016-04-08Buy85,000$3.228.7view
SCHIMMEL PAULDirector 2016-04-07Buy40,000$3.199.72view
SCHIMMEL PAULDirector 2016-04-06Buy25,000$3.29.38view
MENDLEIN JOHNCEO and Director 2016-04-05Buy2,500$3.55-1.41view
SCHIMMEL PAULDirector 2016-04-05Buy25,000$3.52-0.57view

Press Releases about LIFE :

Quarterly/Annual Reports about LIFE:

News about LIFE:

Articles On GuruFocus.com

More From Other Websites
aTyr Pharma to Present at Upcoming May Investor Conferences Apr 29 2016
aTyr Pharma to Present at Upcoming May Investor Conferences Apr 29 2016
ATYR PHARMA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Apr 13 2016
aTyr Pharma (LIFE) Jumps: Stock Adds 13.1% in Session Apr 12 2016
aTyr Pharma (LIFE) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation... Apr 07 2016
aTyr Pharma to Present at 15th Annual Needham & Company Healthcare Conference Apr 06 2016
aTyr Pharma to Present at 15th Annual Needham & Company Healthcare Conference Apr 06 2016
ATYR PHARMA INC Financials Apr 05 2016
Atyr Pharma reports 4Q loss Mar 30 2016
Atyr Pharma reports 4Q loss Mar 30 2016
aTyr Pharma Appoints Sanjay Shukla, MD, MS, as Chief Medical Officer Mar 30 2016
aTyr Pharma Announces Fourth Quarter 2015 Operating Results Mar 30 2016
aTyr Pharma Announces Encouraging Phase 1b/2 Results for Resolaris™ in its First Rare Myopathy... Mar 30 2016
ATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events,... Mar 30 2016
aTyr Pharma Announces Fourth Quarter 2015 Operating Results Mar 30 2016
aTyr Pharma Announces Encouraging Phase 1b/2 Results for Resolaris™ in its First Rare Myopathy... Mar 30 2016
aTyr Pharma Appoints Sanjay Shukla, MD, MS, as Chief Medical Officer Mar 30 2016
aTyr Pharma (LIFE) Shows Strength: Stock Moves Up 10.6% Feb 25 2016
ATYR PHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Jan 29 2016
CryoLife Completes Acquisition of On-X Life Technologies Holdings, Inc. Jan 20 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)